CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner
Top Cited Papers
Open Access
- 17 October 2005
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 202 (8) , 1075-1085
- https://doi.org/10.1084/jem.20051511
Abstract
Tumor growth promotes the expansion of CD4+CD25+ regulatory T (T reg) cells that counteract T cell–mediated immune responses. An inverse correlation between natKeywords
This publication has 47 references indexed in Scilit:
- Natural Killer Cell Signaling PathwaysScience, 2004
- NKG2D Recognition and Perforin Effector Function Mediate Effective Cytokine Immunotherapy of CancerThe Journal of Experimental Medicine, 2004
- A Direct Role for NKG2D/MICA Interaction in Villous Atrophy during Celiac DiseaseImmunity, 2004
- Human CD4+CD25+ regulatory T cellsSeminars in Immunology, 2004
- CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curativeEuropean Journal of Immunology, 2004
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 2002
- What is a natural killer cell?Nature Immunology, 2002
- Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte ResponsesThe Journal of Experimental Medicine, 2001
- Cell Contact–Dependent Immunosuppression by Cd4+Cd25+Regulatory T Cells Is Mediated by Cell Surface–Bound Transforming Growth Factor βThe Journal of Experimental Medicine, 2001
- Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICAScience, 1999